Kawasaki disease

Taubert KA, Rowley AH, Shulman ST: Seven-year national survey of Kawasaki disease and acute rheu-matic fever. Pediatr Infect Dis J 1994, 13:704–708. Davis RL, Waller PL, Mueller BA, et al.: Kawasaki syndrome in Washington state. Race-specific incidence rates and residential proximity to water. Arch Pediatr Adolesc Med 1995, 149:66–69. Yanagawa H, Yashiro M, Nakamura Y, et al.: Epidemio-logic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics 1995, 95:475–479. Leung DYM, Giorno RC, Kazemi LV, et al.: Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol 1995, 155:5018–5021. Daniels SR, Specker B: Association of rug shampooing and Kawasaki disease. J Pediatr 1991, 118:485–488. Rowley AH, Eckerley CA, Jack HM, et al.: IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997, 159(12):5946–5955. Leung DWM, Meissner HC, Schlievert PM: The etiology and pathogenesis of Kawasaki disease. How close are we to an answer? Curr Opin Infect Dis 1997, 86:317–318. Dajani AS, Taubert KA, Gerber MA, et al.: Diagnosis and therapy of Kawasaki disease in children. Circulation 1993, 87:1776–1780. Tanaka N, Naoe S, Masuda H, Ueno T: Pathological study of sequelae of Kawasaki disease (MCLS). With special reference to the heart and coronary arterial lesions. Acta Pathol Jpn 1986, 36:1513–1527. Takahashi M, Shimada H, Billingham ME, et al.: Electron microscopic findings of myocardial biopsy correlated with perfusion scan and coronary angiog-raphy in chronic Kawasaki syndrome: myocellular ischemia possibly due to microvasculopathy. In Kawasaki Disease. Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, May 22–25, 1995. Edited by Kato H. The Netherlands: Elsevier Science BV; 1995:401–410. Kato H, Sugimura T, Akagi T, et al.: Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996, 94:1379–1385. This review is the longest, largest, and most comprehensive study of the natural history of Kawasaki disease. Gidding SS, Shulman ST, Ilbawi M, et al.: Mucocutane-ous lymph node syndrome (Kawasaki disease): delayed aortic and mitral insufficiency secondary to active valvulitis. J Am Coll Cardiol 1986, 7:894–897. de Zorzi A, Colan SD, Gauvreau K, et al.: Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998, 133:254–258. Dajani AS, Taubert KA, Takahashi M, et al.: Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994, 89:916–922. These guidelines define the standard of care for long-term management of Kawasaki disease. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF: The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995, 96:1057–1061. This meta-analysis examines all studies published before 1995 on the treatment of Kawasaki disease with gamma globulin and aspirin. Newburger JW, Takahashi M, Beiser AS, et al.: A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991, 324:1633–1639. Burns JC, Capparelli EV, Brown JA, Newburger JW: Intravenous gamma globulin treatment and retreat-ment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998, 17:1144–1148. Newburger JW: Treatment of Kawasaki disease: corticosteroids revisited [editorial]. J Pediatr 1999, 135:411–413. This editorial contains references to manuscripts published on the steroid treatment of Kawasaki disease. Ino T, Akimoto K, Ohkubo M, et al.: Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease. Circulation 1996, 93:1709–1715. This is a small case series of percutaneous transluminal coronary angioplasty results in Kawasaki disease. Sugimura T, Yokoi H, Sato N, et al.: Interventional treat-ment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease. Circulation 1997, 96:3928–3933. This small case series includes description of rotational ablation of calcification in coronary arteries prior to percutaneous angioplasty. Kitamura S, Kameda Y, Seki T, et al.: Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. J Thorac Cardiovasc Surg 1994, 107:663–674. This large series provides the longest follow-up of children with Kawasaki disease undergoing coronary artery bypass grafts in Japan. Checchia PA, Pahl E, Shaddy RE, Shulman ST: Cardiac transplantation for Kawasaki disease. Pediatrics 1997, 100:695–699. Matsubara T, Yabuta K, Furukawa S: Immunoregulation and pentoxifylline therapy during acute Kawasaki disease. In Kawasaki Disease. Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, May 22–25, 1995. Edited by Kato H. The Netherlands: Elsevier Science BV; 1995:237–240. Villain E, Kachaner J, Sidi D, et al.: Trial of prevention of coronary aneurysm in Kawasaki’s using plasma exchange or infusion of immunoglobulins [in French]. Arch Fr Pediatr 1987, 44:79–83.